Advertisement

Knee Swelling and Rash

  • Ross Petty
  • Farhad Salehzadeh
Chapter

Abstract

  • The EULAR criteria suggests a diagnosis of Henoch Schonlein purpura (HSP) to be made based on palpable purpura with lower limb predominance and at least one of the symptoms of abdominal pain, arthritis or arthralgia or signs of renal involvement or evidence of vasculitis in histopathology

  • The prognosis is excellent for most children with HSP

  • Approximately 20% of children with HSP develop renal involvement which could bear significant mortality and morbidity

Keywords

Henoch Schonlein purpura Palpable purpura Arthritis 

References

  1. 1.
    Ozen S, Pistorio A, Iusan SM, et al. Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798–806.CrossRefGoogle Scholar
  2. 2.
    Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum. 1990;33:1114–21.CrossRefGoogle Scholar
  3. 3.
    Altug UEC, Sayin DB, Ensari A. MEFV gene mutations in Henoch-Schönlein purpura. Int J Rheum Dis. 2013;16(3):347–51.CrossRefGoogle Scholar
  4. 4.
    King B, Goolhoed G. Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions. J Paediatr Child Health. 2003;39:677–81.CrossRefGoogle Scholar
  5. 5.
    Michel B, Hunder G, Bloch D, Calabrese L. Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the 2 disorders. J Rheumatol. 1992;19(5):721–8.PubMedGoogle Scholar
  6. 6.
    Ozen S, Ben-Chetrit E, Bakkaloglu A, et al. Semin Arthritis Rheum. 2001;30:281–7.  https://doi.org/10.1053/sarh.2001.19958.CrossRefPubMedGoogle Scholar
  7. 7.
    Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, Klein NJ, Brogan PA. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476–85.CrossRefGoogle Scholar
  8. 8.
    Trachtman H. HUS and TTP in children. Pediatr Clin North Am. 2013;60:1513–26.CrossRefGoogle Scholar
  9. 9.
    Tarr P, Gordon C, Chandler W. Shiga-toxin-producing Escherichia coli and hemolytic uremic syndrome. Lancet (London, England). 2005;365:1073–86.Google Scholar
  10. 10.
    M. P. Henoch–Schönlein purpura nephritis. Pediatr Nephrol (Berlin Germany). 2015;30:245–52.CrossRefGoogle Scholar
  11. 11.
    Ronkainen J, Ala-Houhala M, Huttenen M, et al. Outcome of Henoch-Schonlein nephritis with nephrotic-range proteinuria. Clin Nephrol. 2003;60:80–4.CrossRefGoogle Scholar
  12. 12.
    Pacheva IH, Ivanov IS, Stefanova K, Chepisheva E, Chochkova L, Grozeva D, Stoyanova A, Milenkov S, Stefanova P, Petrova A. Central nervous system involvement in Henoch-Schonlein Purpura in children and adolescents. Case Rep Pediatr. 2017;2017:6.Google Scholar
  13. 13.
    Chartapisak W, Opastiraku S, Willis NS. Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review. Arch Dis Child. 2009;94:132–7.CrossRefGoogle Scholar
  14. 14.
    Inoue CN, Chiba Y, Morimoto T, Nishio T, Kondo Y, Adachi M, Matsutani S. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis. Clin Nephrol. 2007;67(5):298–305.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Ross Petty
    • 1
  • Farhad Salehzadeh
    • 2
  1. 1.Pediatric RheumatologyUniversity of British ColumbiaVancouverCanada
  2. 2.Pediatric RheumatologyBouali Children’s Hospital, ARUMSArdabilIran

Personalised recommendations